Mmmmm.....
- results from both stages of the ARDS trial by end of August
- next quarterly announcing a record quarter for the company (end of July)
- interim decision by the TGA on over-the-counter sales of Cannabis by 9th September 2020 (https://www.dlapiper.com/en/australia/insights/publications/2020/05/australia-considers-over-the-counter-cbd---snapshot-of-new-proposal/)
- initiation and quite possibly completion of the OSA trial
- commencement of the TBI animal trials potentially this month but more likely next month
Do we think that these may be catalysts for a surge in the SP just in time for options (IHLOB) conversion before the 30 Sept deadline
- Forums
- ASX - By Stock
- IHL
- Ann: IHL commences IHL-675 (ARDS) animal study
Ann: IHL commences IHL-675 (ARDS) animal study, page-61
-
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)